Promega
CellTiter-Glo® 2.0 Cell Viability Assay
#G9712
Research areas
Neuroblastoma Research and Treatments4Renal Diseases and Glomerulopathies4Neuroendocrine Tumor Research Advances3Antimicrobial Peptides and Activities3Complement system in diseases3Coagulation, Bradykinin, Polyphosphates, and Angioedema3Herpesvirus Infections and Treatments3Lung Cancer Research Studies3
Papers citing this product
3
5
6
Similar products
| Product | Vendor | Price | Papers |
|---|---|---|---|
| CellTiter-Glo® 2.0 Cell Viability Assay | Promega | — | 100 |
| CellTiter-Glo® 2.0 Cell Viability Assay | Promega | — | 100 |
| CellTiter-Glo® 2.0 Cell Viability Assay | Promega | — | 100 |
| CellTiter-Glo® 2.0 Cell Viability Assay | Promega | — | 100 |
| CellTiter-Glo® 2.0 Cell Viability Assay | Promega | — | 100 |
| CellTiter-Glo® 2.0 Cell Viability Assay | Promega | — | 85 |
| CellTiter-Glo® 2.0 Cell Viability Assay | Promega | — | 40 |
| CellTiter-Glo® 2.0 Cell Viability Assay | Promega | — | 18 |
| CellTiter-Glo® 2.0 Cell Viability Assay | Promega | — | 15 |
| CellTiter-Glo® 2.0 Cell Viability Assay | Promega | — | 15 |
| CellTiter-Glo® 2.0 Cell Viability Assay | Promega | — | 8 |
| CellTiter-Glo® 2.0 Cell Viability Assay | Promega | — | 7 |
| CellTiter-Glo® 2.0 Cell Viability Assay | Promega | — | 5 |
| CellTiter-Glo® 2.0 Cell Viability Assay | Promega | — | 4 |